535 related articles for article (PubMed ID: 32993066)
21. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
[TBL] [Abstract][Full Text] [Related]
23. [New directions of pharmacotherapy of immune - inflammatory rheumatic diseases].
Nasonov EL
Ter Arkh; 2019 Aug; 91(8):98-107. PubMed ID: 32598760
[TBL] [Abstract][Full Text] [Related]
24. [Biological therapy of arthritis and systemic autoimmune diseases].
Tamási L; Szekanecz Z
Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
Gottenberg JE; Dörner T; Bootsma H; Devauchelle-Pensec V; Bowman SJ; Mariette X; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Wegener WA; Goldenberg DM; Meno-Tetang G; Kosutic G; Gordon C
Arthritis Rheumatol; 2018 May; 70(5):763-773. PubMed ID: 29381843
[TBL] [Abstract][Full Text] [Related]
26. [Immunology and rheumatic diseases. History and current aspects].
Bonomo L
Recenti Prog Med; 1976 Dec; 61(6):741-8. PubMed ID: 1088188
[No Abstract] [Full Text] [Related]
27. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y
Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406
[TBL] [Abstract][Full Text] [Related]
28. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
[TBL] [Abstract][Full Text] [Related]
29. IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases.
Blanco F; Kalsi J; Ravirajan CT; Speight P; Bradwell AR; Isenberg DA
Lupus; 1992 Dec; 1(6):391-9. PubMed ID: 1304408
[TBL] [Abstract][Full Text] [Related]
30. Emerging role of interleukin-22 in autoimmune diseases.
Pan HF; Li XP; Zheng SG; Ye DQ
Cytokine Growth Factor Rev; 2013 Feb; 24(1):51-7. PubMed ID: 22906768
[TBL] [Abstract][Full Text] [Related]
31. Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases?
Galarza C; Valencia D; Tobón GJ; Zurita L; Mantilla RD; Pineda-Tamayo R; Rojas-Villarraga A; Rueda JC; Anaya JM
Clin Rev Allergy Immunol; 2008 Feb; 34(1):124-8. PubMed ID: 18270866
[TBL] [Abstract][Full Text] [Related]
32. [Inflammatory rheumatism within the framework of autoimmune diseases].
Van Slype J
J Belge Rhumatol Med Phys; 1967; 22(4):204-7. PubMed ID: 4185872
[No Abstract] [Full Text] [Related]
33. Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases.
Muraoka S; Nishio J; Kuboi Y; Imai T; Nanki T
Expert Opin Biol Ther; 2020 Nov; 20(11):1309-1319. PubMed ID: 32401060
[No Abstract] [Full Text] [Related]
34. Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity.
Molano-González N; Rojas M; Monsalve DM; Pacheco Y; Acosta-Ampudia Y; Rodríguez Y; Rodríguez-Jimenez M; Ramírez-Santana C; Anaya JM
J Autoimmun; 2019 Mar; 98():24-32. PubMed ID: 30459097
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune rheumatic diseases in women.
Schuna AA
J Am Pharm Assoc (Wash); 2002; 42(4):612-23; quiz 623-4. PubMed ID: 12150360
[TBL] [Abstract][Full Text] [Related]
36. [Use of immunodiffusion (RID) for quantiative evaluation of immunoglobulins in the rheumatological field].
Biddau A; Bartoletti L; Doni A
Reumatismo; 1968; 20(5):545-9. PubMed ID: 4186692
[No Abstract] [Full Text] [Related]
37. Autoantibodies in the diagnosis of systemic rheumatic diseases.
von Mühlen CA; Tan EM
Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
[TBL] [Abstract][Full Text] [Related]
38. Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study.
Tsirves GK; Voulgari PV; Pelechas E; Asimakopoulos AD; Drosos AA
Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2419-2426. PubMed ID: 31175453
[TBL] [Abstract][Full Text] [Related]
39. Clinical and immunological parameters of Sjögren's syndrome.
Psianou K; Panagoulias I; Papanastasiou AD; de Lastic AL; Rodi M; Spantidea PI; Degn SE; Georgiou P; Mouzaki A
Autoimmun Rev; 2018 Oct; 17(10):1053-1064. PubMed ID: 30103041
[TBL] [Abstract][Full Text] [Related]
40. Proinflammatory cytokines (IL-12 and IL-18) in immune rheumatic diseases: relation with disease activity and autoantibodies production.
Mosaad YM; Metwally SS; Auf FA; AbdEL-Samee ER; el-Deek B; Limon NI; el-Chennawi FA
Egypt J Immunol; 2003; 10(2):19-26. PubMed ID: 15719608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
